Leukemic Cluster Growth in Culture Is an Independent Risk Factor for Acute Myeloid Leukemia and Short Survival in Patients with Myelodysplastic Syndrome

Publisher： Karger

E-ISSN： 1421-9662|119|4|226-235

ISSN： 0001-5792

Source： Acta Haematologica, Vol.119, Iss.4, 2008-06, pp. : 226-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis in Acute Myeloid Leukemia and Myelodysplastic Syndrome

By  

Acta Haematologica, Vol. 106, Iss. 4, 2002-01 ,pp. : 170-176

Karger

Access to resources Recommend Favorite

Idarubicin, cytarabine, and pravastatin as induction therapy for untreated acute myeloid leukemia and high‐risk myelodysplastic syndrome

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 6, 2015-06 ,pp. : 483-486

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I/II trial of the combination of midostaurin (PKC412) and 5‐azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 4, 2015-04 ,pp. : 276-281

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population‐based study among older breast cancer patients

By  

CANCER, Vol. 124, Iss. 5, 2018-03 ,pp. : 899-906

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fatal Hepatic Veno-Occlusive Disease in a Phase I Study of Mylotarg and Troxatyl in Patients with Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

By  

Acta Haematologica, Vol. 108, Iss. 3, 2002-09 ,pp. : 164-167

Karger

Access to resources Recommend Favorite